Abbott reports positive Simcor trial results

11/4/2007 | CNNMoney

Abbott Laboratories' cholesterol-lowering treatment Simcor significantly reduced "bad" LDL cholesterol and improved "good" HDL cholesterol compared to simvastatin during its Phase III clinical trial. The company hopes to get regulatory approval for Simcor, a combination of simvastatin and another drug from Abbott, during the first quarter of 2008.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Abbott
Santa Ana, CA